- 3 mins |
- Mar 29 2024
Myasthenia gravis is a debilitating autoimmune condition with impaired signals between nerves and muscles, leading to muscle weakness and fatigue. A recent study has demonstrated that a new chemical compound named NMD670 shows promise in restoring the signalling at the neuromuscular junction, thereby improving muscle strength.